Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007195 |
---|---|
Receipt number | R000008473 |
Scientific Title | Phase II Study of XELOX and Cetuximab as First Line Therapy in Patients with Wild Type KRAS Metastatic Colorectal Cancer |
Date of disclosure of the study information | 2012/02/01 |
Last modified on | 2018/09/20 08:25:05 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/01 17:58:16 | ||
2 | Update | 2012/02/05 21:37:56 | Public title |
|
3 | Update | 2012/06/08 10:15:27 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Email1 |
|
4 | Update | 2012/08/29 12:52:07 | Email |
|
5 | Update | 2012/10/10 14:53:07 | Email1 |
|
6 | Update | 2012/11/01 21:52:12 | Public title Public title |
|
7 | Update | 2013/02/01 10:08:33 | Recruitment status |
|
8 | Update | 2013/09/01 17:23:05 | Email Last name of contact person Last name of contact person Address |
|
9 | Update | 2016/04/04 16:08:54 | Name of primary person or sponsor Organization |
|
10 | Update | 2016/08/19 09:46:11 | Recruitment status Publication of results Results |
|
11 | Update | 2016/08/19 09:58:27 | Results Other related information |
|
12 | Update | 2018/09/20 08:25:05 | Recruitment status |